About the Program

About the Program

The Clinical Guidelines Program is a collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute, Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.

History: The NYSDOH AI Guidelines Program began in the late 1980s in response to the clinical management challenges of the HIV/AIDS epidemic in New York, and has continuously provided clinical guidance for HIV care providers in New York State. As the AIDS Institute has expanded its mission over time, so has this program, which now publishes evidence-based, timely clinical practice guidelines for HIV care and prevention, and for treatment of viral hepatitis, other sexually transmitted infections, and substance use disorders. Like the AIDS Institute, the clinical guidelines program also addresses healthcare and prevention for  the LGBTQ community.

Mission: To produce and disseminate evidence-based, state-of-the-art clinical practice guidelines that establish  uniform standards of care for practitioners who provide prevention or treatment of HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders for adults throughout New York State in the wide array of settings in which those services are delivered.

Goals: As part of the AI Quality of Care Programs, the goal of the Clinical Guidelines Program is to support care providers in improving the health and well being of adults in New York State who have or are at risk of acquiring HIV, viral hepatitis, other sexually transmitted infections, and substance use orders. The Guidelines Program also supports the New York State Ending the Epidemic Initiative, including the HIV treatment-as-prevention (TasP) strategy, with strong recommendations for increased testing and linkage to care, immediate initiation of antiretroviral therapy, increased awareness of acute HIV infection, and dedicated efforts to maintain HIV viral load suppression.

Expert committees: The AIDS Institute Medical Director invites and appoints committees of clinical and public health experts from throughout NYS to ensure that the guidelines are practical, immediately applicable, and meet the needs of care providers and stakeholders in all major regions of NYS, all relevant clinical practice settings, key NYS agencies, and community service organizations.

Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.

Audience: AI clinical care guidelines are produced and disseminated to clinicians in New York State who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs, and substance use disorders. Guideline recommendations are based on published evidence and the collective expertise of committee members and are practical for use by specialists and low-volume care providers. All involved are committed to publishing guidelines that are used in the real world by busy care providers, who find them to be useful and readily accessible tools with immediate application in daily practice.

The AI has always sought to publish guidelines that inform primary care providers who do not specialize in HIV but who do provide care for people with HIV within New York State. The guidelines are grounded in current research, supported by evidence, and reflect the breadth of experience of committee members who specialize in HIV, HCV, STIs, and substance use and who know the realities of providing clinical care throughout New York State and in a broad array of clinical settings.

Dissemination and implementation: All clinical care guidelines are freely accessible and are published at www.hivguidelines.org. The AI disseminates the guidelines through multiple channels and numerous programs, and the Clinical Education Initiative provides training for care providers in New York State in support of guideline implementation.

JHU Clinical Guidelines Program: The JHU School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AI since 1999 to develop and disseminate the AI clinical guidelines and related quality-of-care information. The Clinical Guidelines program website is managed by the JHU program.

Funding: The Clinical Guidelines Program is supported by New York State funds allocated through a grant to the JHU School of Medicine to support all activities of the program.

 

Program Leadership and Staff

New York State Department of Health AIDS Institute: The Office of the Medical Director (OMD) oversees the program.

  • Charles J. Gonzalez, MD, Medical Director
  • Lyn Stevens, MS, NP, ACRN, Clinical Advisor to the AIDS Institute
  • Laura Duggan Russell, MPH, AI Guidelines Program Director

The AIDS Institute OMD consists of public health professionals dedicated to enhancing the quality of life for persons with HIV by improving prevention and health care services through performance measurement and science-based initiatives. The Office of the Medical Director oversees numerous programs and initiatives including:

NYSDOH AI contact information: Laura Russell, Program Director: laura.russell@health.ny.gov.
New York State Department of Health AIDS Institute, Office of the Medical Director, 90 Church Street, 13th Floor, New York, New York 10007-2919

Johns Hopkins University School of Medicine Clinical Guidelines Program: The Johns Hopkins University School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AIDS Institute since 1999 to develop and disseminate HIV clinical guidelines and related quality-of-care information.

Christopher J. Hoffmann, MD, MPH, Director, JHU-NYSDOH AI Guidelines Program, provides leadership and strategy to the program and lends extensive experience in both HIV clinical care and guidelines development, as well as a resolute commitment to training for HIV care providers.

The JHU team manages all aspects of guidelines development and dissemination and program administration through the efforts of the following program staff:

  • Mary Beth Hansen, MA, Program Director
  • Jennifer R Ham, MPH, Senior Medical Editor
  • Johanna L Gribble, MA, Senior Medical Editor
  • Rachel Lastra, Senior Medical Editor
  • Jesse M Ciekot, Program Administrator

JHU contact information: Mary Beth Hansen, Program Director: mbh@jhmi.edu or Jesse Ciekot, Program Administrator: jciekot@jhmi.edu. General questions about the website can be emailed to:  aiguidelines@jhmi.edu.

Guideline Development

Expert committee composition: The Clinical Guidelines Program works directly with committees composed of experts in the field who represent multiple disciplines (medicine, nursing, psychology, pharmacy, public health, social work, mental health), clinical specialties (infectious diseases, family medicine, obstetrics and gynecology, hepatology, pediatrics, psychiatry, dentistry, prevention, etc.), and various geographic regions of New York State.

A Clinical Guidelines Program Steering Committee provides oversight and strategy to the following Clinical Guidelines Program committees, each of which is responsible for developing and updating clinical practice guidelines that fall under its area of expertise. Current committees (August 2023) include the following:

Financial disclosure and confidentiality agreement: All potential and active committee members are required to sign a confidentiality agreement and to disclose annually all financial relationships with commercial entities or gifts that may be actual, potential, or perceived as conflicts of interest. Committee members must report financial relationships with commercial entities that have existed in the 12 months prior to or are expected to exist in the 12 months after the date on which they sign their disclosure form.

Guideline development process: When the Clinical Guidelines Program identifies the need to develop or update a guideline, the committee under whose purview the guideline falls convenes to determine the goals of the guideline and its content, review the published literature, and weigh new evidence for recommendations. Text is then drafted by an author who has experience with the topic of the guideline. The guideline draft is edited by the team at JHU, and then reviewed and modified by the committee. This rigorous development process may entail multiple rounds of review, revision, rating, and editing. Decision-making occurs by consensus, and all guideline recommendations are reviewed by and receive the consensus approval of the full guideline committee.

Evidence-based Recommendations: All recommendations are rated to reflect the strength of each recommendation and the quality of the supporting evidence. Ratings are reached through review of the evidence and consensus decision. If the published evidence in support of a particular recommendation is not sufficient, the group relies on collective best practices experience to develop a final statement. The rating scheme for recommendations appears below.

Recommendation Ratings Scheme
Strength Quality of Evidence
Rating Definition Rating Definition
A Strong 1 Based on published results of at least 1 randomized clinical trial with clinical outcomes or validated laboratory endpoints.
B Moderate * Based on either a self-evident conclusion; conclusive, published, in vitro data; or well-established practice that cannot be tested because ethics would preclude a clinical trial.
C Optional 2 Based on published results of at least 1 well-designed, nonrandomized clinical trial or observational cohort study with long-term clinical outcomes.
2† Extrapolated from published results of well-designed studies (including nonrandomized clinical trials) conducted in populations other than those specifically addressed by a recommendation. The source(s) of the extrapolated evidence and the rationale for the extrapolation are provided in the guideline text. One example would be results of studies conducted predominantly in a subpopulation (e.g., one gender) that the committee determines to be generalizable to the population under consideration in the guideline.
3 Based on committee expert opinion, with rationale provided in the guideline text.

External review: All guidelines are reviewed by external experts in the field and by the AIDS Institute’s Consumer Advisory Committee.

Final approval: The guideline is submitted to the AIDS Institute for review and final approval prior to publication. The AI may request additional review by other agencies and organizations when applicable.

Guideline Updates: Members of guideline committees monitor developments ongoing to maintain guideline currency, at regular intervals. Newly published data that provides support for existing recommendations will be cited in the text and the studies will be added to the reference list. If newly published data prompts a revision to recommendations or rationale, a planning committee proposes appropriate edits and determines whether any changes warrant full committee review and approval.

Medical Care Criteria Committee (MCCC; Adult HIV Treatment and Prevention)

Updated  August 2023
→ Committee member has no disclosures unless otherwise noted. 

Writing Group

Chair:  Steven M. Fine, MD, PhD
Professor of Clinical Medicine, University of Rochester Medical Center, Rochester, NY

Vice-Chair:  Rona M. Vail, MD
Lead HIV Clinician, Callen-Lorde Community Health Center, New York, NY

Chair Emeritus: Joseph P. McGowan, MD, FACP, FIDSA
North Shore University Hospital, Manhasset, NY

Chair Emeritus: Samuel T. Merrick, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY

Transgender Health Specialist: Asa E. Radix, MD, MPH, PhD, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY

Community Advisor:  Jessica Rodrigues, MS
Senior HIV/Family Planning Advisor,  USAID Office of HIV/AIDS, New York, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

Contributing Members

Elizabeth A. Asiago-Reddy, MD, MS
SUNY Upstate Medical University, Syracuse, NY

Jessica M. Atrio, MD, MSc
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

James C. M. Brust, MD
Professor of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Michelle S. Cespedes, MD, MS
Icahn School of Medicine at Mount Sinai, New York, NY
Scientific advisor: Gilead, ViiV

Ethan A. Cowan, MD, MS
Icahn School of Medicine at Mount Sinai, New York, NY

Mary E. Dyer, MD
Sun River Health, Poughkeepsie, NY

John J. Faragon, PHARMD, BCPS, AAHIVP
Albany Medical Center, Albany, New York
Scientific advisor: ViiV

Shauna H. Gunaratne, MD, MPH, DTM&H
Columbia University Medical Center, New York, NY

Bruce E. Hirsch, MD, FACP, FIDSA, AAHIVS
North Shore University Hospital, Manhasset, NY

Christine A. Kerr, MD
Galileo Health

Jeremy D. Kidd, MD, MPH
New York-Presbyterian Hospital, Columbia University, New York, NY

Hector I. Ojeda-Martinez, MD
Nuvance Health/Health Quest Medical Practice, Poughkeepsie, NY

Meera Shah, MD, MPH, MS, AAHIVS
Planned Parenthood Hudson Peconic, Elmsford, NY

Sanjiv S. Shah, MD, MPH, AAHIVM, AAHIVS
NYC Health + Hospitals/Gotham Health, Gouverneur, New York, NY

Eugenia L. Siegler, MD
Weill Cornell Medical College, New York, NY

Maria Teresa (Tess) Timoney, MS, RN, CNM
Bronx Prevention Center, ICAP at Columbia, Bronx, NY

Benjamin W. Tsoi, MD, MPH
Director of HIV Prevention, Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene, New York, NY

Marguerite A. Urban, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY

Antonio E. Urbina, MD
Professor of Medicine, The Mount Sinai Hospital, Comprehensive Health Program-Downtown, New York, NY
Scientific advisor: Gilead, Janssen, Merck, ViiV

Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY

Changes to MCCC Membership

June 2022: New contributing members: Elizabeth A. Asiago-Reddy, MD, MS, SUNY Upstate Medical University, Syracuse, NY; Michelle S. Cespedes, MD, MS, Icahn School of Medicine at Mount Sinai, New York, NY

April 2022: Appointed Chair:  Steven M. Fine, MD, PhD, University of Rochester Medical Center, Rochester, NY. Appointed Chair Emeritus: Joseph P. McGowan, MD, FACP, FIDSA, North Shore University Hospital, Manhasset, NY

January 2022: New contributing member: Meera Shah, MD, MPH, MS, AAHIVS, Planned Parenthood Hudson Peconic. Stepped down: Oni J. Blackstock, MD, MHS, Health Justice

August 2021: Stepped down: Elliot DeHaan, MD,  New York-Presbyterian Hospital/Weill Cornell Medical Center; Noga Shalev, MD, Columbia University Medical Center

July 2021: New writing group member: Jessica Rodrigues, AVAC

March 2021: New contributing members: John J. Faragon, PHARMD, BCPS, AAHIVP, Albany Medical Center; Shauna H. Gunaratne, MD, MPH, Columbia University Medical Center; Bruce E. Hirsch, MD, FACP, FIDSA, AAHIVS, North Shore University Hospital. Stepped down: John M. Conry, PharmD, AAHIVP, FNAP, St. John’s University; Annette Gaudino, Treatment Action Group (TAG); Jeremiah Johnson, Treatment Action Group (TAG); Eugene D. Morse, PharmD, FCCP, BCPS, University at Buffalo School of Pharmacy & Pharmaceutical Sciences

February 2021: New contributing member: Benjamin W. Tsoi, MD, MPH,  Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene

July 2020: New contributing member: Ethan A. Cowan, MD, MS, Icahn School of Medicine at Mount Sinai. Stepped down: Daniel J. Egan, MD, Columbia University Vagelos College of Physicians and Surgeons

January 2020: New contributing members: Jessica M. Atrio, MD, MSc, Albert Einstein College of Medicine/Montefiore Medical Center; Oni J. Blackstock, MD, MHS, New York City Department of Health and Mental Hygiene. Stepped down: Julie E. Myers, MD, MPH, New York City Department of Health and Mental Hygiene

December 2019: Stepped down: Jack Fuhrer, MD, Stony Brook University School of Medicine; Luz Amarilis Lugo, MD, Mount Sinai Comprehensive Health Program-Downtown; Cynthia H. Miller, MD, Albany Medical Center; David C. Perlman, MD, Icahn School of Medicine at Mount Sinai

Hepatitis C Virus (HCV) Guideline Committee

Updated August 2023
→ Committee member has no disclosures unless otherwise noted.

Writing Group

Chair: Joshua S. Aron, MD
Elmhurst Hospital Center, Elmhurst, NY

Chair Emerita: Christine A. Kerr, MD
Galileo Health

Contributor: David E. Bernstein, MD, MACG, FAASLD, AGAF, FACP
NYU Langone Health, New York, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

AIDS Institute Clinical Representative, Viral Hepatitis: Colleen Flanigan, RN, MS
Bureau of Hepatitis Health Care and Epidemiology, New York State Department of Health AIDS Institute, Albany, NY

Contributing Members 

Mary Angerame, MS, APN-BC
Jordan Health, Rochester, NY

Ayse Aytaman, MD, AGAF, FACG
Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY

Donald P. Kotler, MD
Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY

Kristen Marks, MD
Weill Cornell Medical College, New York, NY

Brianna L. Norton, DO, MPH
Montefiore Medical Group, Bronx, NY

Andrew H. Talal, MD, MPH
SUNY Buffalo , Buffalo, NY
Scientific advisor:  Abbott, Merck; honorarium recipient: Gilead

Jeffrey J. Weiss, PhD, MS
Mount Sinai School of Medicine, New York, NY

Changes to the HCV Guideline Committee

April 2021: New contributing member: Andrew H. Talal, MD, MPH, SUNY Buffalo

March 2021: New contributing member: Donald P. Kotler, MD, Albert Einstein College of Medicine/Jacobi Medical Center. Stepped down: Annette Gaudino, Treatment Action Group (TAG)

September 2020: Stepped down: Ponni V. Perumalswami, MD, Icahn School of Medicine at Mount Sinai

February 2020: Appointed Vice-Chair: Ponni V. Perumalswami, MD, Icahn School of Medicine at Mount Sinai. Appointed Chair Emerita: Christine A. Kerr, MD, Galileo Health

Perinatal Transmission Prevention Guideline Committee

Updated March 2021
→ Committee member has no disclosures unless otherwise noted.

Leadership

Chair: Marc D. Foca, MD
Children’s Hospital at Montefiore Albert Einstein College of Medicine, Bronx, NY

Chair Emeritus: Rodney L. Wright, MD, MS
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Chair Emeritus: Murli U. Purswani, MBChB, FAAP
Bronx-Lebanon Hospital Center, Bronx, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

AIDS Institute Clinical Representative, Perinatal HIV Prevention: Suzanne Kaufman, MPH, BSN, AACRN
New York State Department of Health AIDS Institute, Albany, NY

Contributing Members

Helene Bernstein, MD, PhD
Upstate Medical University, Syracuse, NY

Aracelis D. Fernández, MD, FAAP
Harlem Hospital Center, New York, NY

Courtney Olson-Chen, MD, MSCI
University of Rochester Medical School, Rochester, NY

Maria Teresa (Tess) Timoney, CNM, NP, MS, RN
Bronx Prevention Center, ICAP at Columbia, Bronx, NY

Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY

Changes to the Perinatal Transmission Prevention Guideline Committee

March 2021: Stepped down: Annette Gaudino, Treatment Action Group (TAG)

Substance Use Guidelines Committee

Updated August 2023
→ Committee member has no disclosures unless otherwise noted.

Leadership

Chair (10/26/21):  Susan D. Whitley, MD
New York City Health + Hospitals/Kings County, Brooklyn, NY

Vice-Chair (10/26/2021): Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM
Director of Addiction Medicine, Associate Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

AIDS Institute Clinical Representative, Harm Reduction in Healthcare: Sharon L. Stancliff, MD
New York State Department of Health AIDS Institute, New York, NY

AIDS Institute Clinical Representative, Drug User Health: Narelle Ellendon, RN
New York State Department of Health AIDS Institute, New York, NY

Contributing Members

Angela G. Giovanniello, PharmD, AAHIVP
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Judith L. Griffin, MD
REACH Medical, Ithaca, NY

Julia K. Hunter, MD, MPH, FASAM
United Health Services Hospitals, Inc., Binghamton, NY

Giliane Joseph, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Tiffany Y. Lu, MD, MS, FASAM
Associate Professor of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Yonina Mar, MBBS, MSc
Mount Sinai Beth Israel, New York, NY

Shadi Nahvi, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY

Sara Lorenz Taki, MD
Greenwich House MMTP, New York, NY

Linda Wang, MD
Icahn School of Medicine at Mount Sinai, New York, NY

Changes to the Substance Use Guidelines Committee

June 2023: New contributing member: Linda Wang, MD, Icahn School of Medicine at Mount Sinai

October 2021: Appointed Chair: Susan D. Whitley, MD, New York City Health + Hospitals/Kings County. Appointed Vice-Chair: Timothy J. Wiegand, MD, University of Rochester Medical Center

August 2021: New contributing members: Judith L. Griffin, MD, REACH Medical; Julia K. Hunter, MD, MPH, FASAM, United Health Services Hospitals, Inc.; Tiffany Y. Lu, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center; Yonina Mar, MBBS, MSc, Mount Sinai Beth Israel; Sara Lorenz Taki, MD, Greenwich House MMTP

June 2021: Stepped down: Hillary Kunins, MD, MPH, MS, New York City Department of Health and Mental Hygiene

April 2021: Stepped down: Chinazo O. Cunningham, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center

March 2021: Stepped down: Annette Gaudino, Treatment Action Group (TAG); Raymond Harvey, MD, Institute for Family Health

July 2020: Stepped down: Marcus Bachhuber, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center; Michael L. Christie, MD, University of Rochester Medical Center; Kelly S. Ramsey, MD, MPH, MA, FACP, New York State Office of Addiction Services and Support

Institutional, Agency, and Program Liaison Advisory Group

Updated September 2023
→ Group member has no disclosures unless otherwise noted.

Sheldon T. Brown, MD
Infectious Diseases, Hudson Valley VA Healthcare System, Montrose, NY

Douglas Fish, MD
Office of Health Insurance Programs, New York State Department of Health, Albany, NY

Emma Kaplan-Lewis, MD
HIV Services, Office of Population Health, NYC Health and Hospitals, New York, NY

Ralph Liporace, MD
Coxsackie Correctional Facility, NYS Department of Corrections and Community Service, Albany NY

Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM
NYS Office of Addiction Services and Supports, Albany, NY

William M. Valenti, MD, FIDSA
Senior Vice President for Strategic Advancement, Chief of Innovation, Staff Physician, Trillium Health, Rochester, NY; Medical Society of the State of New York

Changes to the Institutional, Agency, and Program Liaison Advisory Group

September 2023: Stepped down: Monica Parker, PhD, Bloodborne Viruses Laboratory, Wadsworth Center, NYSDOH

About This Website

Purpose: The NYSDOH AI Clinical Guidelines website publishes the clinical practice guidelines and related materials produced by the Clinical Guidelines Program. The program is a collaborative effort of the New York State Department (NYSDOH) of Health AIDS Institute’s (AI) Office of the Medical Director (OMD) and the Johns Hopkins University School of Medicine, Division of Infectious Diseases. This website is maintained and managed by the JHU Clinical Guidelines program, within the Johns Hopkins University School of Medicine, Division of Infectious Diseases.

Production and development :

  • WordPress development and programming: Patrick Harris, Cyberian Frontier
  • Graphic design: Laura Hatcher, Hatcher Design Office
  • Managing Editor: Mary Beth Hansen
  • Website production: Johanna L Gribble

Editorial policies and procedures: This website is produced and maintained by the JHU Clinical Guidelines Program at the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. The site does not purport to advance any official positions of JHU, the JHU School of Medicine, or the Division of Infectious Diseases. The JHU Clinical Guidelines Program, in collaboration with the NYSDOH AI, maintains editorial control of all materials published on this site, and unless noted otherwise, all materials posted on this site have been produced under the auspices NYSDOH AIDS Institute Clinical Guidelines Program.

Mention of specific products by generic or brand name does not constitute an endorsement by the Clinical Guidelines Program, or its committee members, editors, or staff; NYSDOH or the AI or its staff. Any mention of specific products is for informational purposes only. Regarding specific products or drugs, physicians and other health care providers are advised to consult their normal resources before prescribing to their patients.

The JHU Clinical Guidelines Program does not provide clinical care and does not provide clinical or medical advice.

Privacy: This website is designed to provide public access to the clinical practice guidelines published by the JHU Clinical Guidelines Program on behalf of and under the direction of the New York State Department of Health AIDS Institute Clinical Guidelines Program. The JHU Clinical Guidelines Program recognizes the importance of protecting the privacy of visitors to the HIV Clinical Guidelines Program website and subscribers to the site mailing list and the monthly Topic, Trends, and Updates e-mail update.

  • Stored information: Most information transmitted over the Internet is not secure; thus, confidentiality cannot be guaranteed. However, of the information transmitted via your visit to the Clinical Guidelines Program website, we store the following: the IP address from which you access the Internet, the date and time, the Internet address of the Website from which you linked directly to our site, the name of the file or the words you searched, and the browser used to access our site. This information is used to measure the number of visitors to the various sections of our site and identify system performance or problem areas. We also use this information to help us improve the features of the site and to make the site more useful.
  • Personally provided information: If you choose to provide us with personal information by sending an email, or by subscribing to one or both of our mailing lists and submitting that information it through our Website, we will use that information to respond to your message, to send you email that you have asked to receive and to help us provide you with information or material that you may request. We do not give, share, sell, or transfer any of your personal information to a third party unless required by law.
    • If you submit a question that would be best answered by a staff member of the NYSDOH AIDS Institute, we may forward your question to that staff member. When we do, we may or may not include your email address so the staff member may respond to you directly. Submitting a question through this website constitutes your tacit agreement with the actions the JHU website managers may take to secure the best answer possible in a timely manner.
  • Links to other sites: For the convenience of those who access and use the content published on this site (i.e., the site users), many pages contain links to Web pages and Websites that are not managed by the JHU Clinical Guidelines program. Neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute Clinical Guidelines Program control or take responsibility for the content of those Websites. Links from this Website to Websites not managed by any of the entities named above do not imply endorsement or credibility of the service, information, or product offered through the linked sites. Links are provided to make it easy for users to access supplementary content.
    • Some pages on this site provide links to other Websites that provide health information. Once a user links to another site, she or he is subject to the privacy policy of that other site.
  • Disclaimer: The information provided in this privacy statement should not be construed as giving business, legal, or other advice, or warranting as fail-proof, the security of information provided through this website.

Terms of use: While every possible effort is made to post accurate and reliable information on this website, neither the JHU Clinical Guidelines Program, neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute HIV Clinical Guidelines Program assumes responsibility for the use or application of information posted on any page of this website or guarantees or warrants that the information posted on any page of this site is complete and without any error or inaccuracy. The website, its editors, advisers, staff, authors, and sponsoring institutions assume no responsibility for any error, omissions, or other discrepancies between the electronic documents published on this site and source materials.

Physicians and other healthcare professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience.

Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition or treatment and are encouraged to call or see their physician or other health care provider promptly with any health-related questions or concerns they may have.

This website links to websites maintained by other entities. Reasonable precautions are taken to link only to websites that publish appropriate and accurate material and are maintained by reputable organizations. However, those web pages are not under the direction or control of this website, and this website can therefore not be held responsible for the information or opinions expressed in those linked sites.

Any use of materials from this site should be accompanied by the following citation of source:

This material was accessed on [dd/mo/year] on the Clinical Guidelines Program website (www.hivguidelines.org). The Clinical Guidelines Program is a collaborative effort of the New York State Department of Health AIDS Institute and the Johns Hopkins University Division of Infectious Diseases. Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2023.

Requests to adapt material, i.e., to change or alter in any way material from this site for inclusion in another publication, should be sent to aiguidelines@jhmi.edu. Please include detailed information about the intended use and desired adaptations.

The names of the New York State Department of Health, the Johns Hopkins University Division of Infectious Diseases, Clinical Guidelines Program, or its staff may not be used in publicity or advertising without express written permission. Exceptions to this include listings on web indexes, search engines, and related systems.

Contact Us

Mailing address:

JHU Clinical Guidelines Program
1550 Orleans Street, CRB II, Office 1M11
Baltimore, MD, 21287-0014

E-mail addresses:

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Please note: The email addresses above are for submission of questions or feedback about the website or the guidelines. The New York State Department of Health AIDS Institute Clinical Guidelines Program is not a clinical consultative service. Individuals should consult with a care provider regarding specific patient needs and circumstances. Questions about individual and specific health issues will not be answered.

 

Join our Mailing List

Stay up-to-date with the monthly Topics, Trends & Updates e-mail: The monthly Topics, Trends & Updates email keeps subscribers up-to-date regarding new and updated clinical guidelines, hot topics, upcoming events, developments in the field, and What We’re Reading.

Privacy: We do not sell, rent, or share our email lists with anyone.

 

Limit 2000 Characters

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact